Immunological profile of treated lepromatous leprosy patients

International Journal of Leprosy and Other Mycobacterial Diseases

Volumn 69, Issue 3, 2001, Pages 195-203

  Joshi, Beenu ^a   Girdhar, Bhawneshwar K ^b   Mohanty, Keshar K ^a   Beuria, Mihir K ^a   Girdhar, Anita ^b   Sengupta, Utpal ^a  

^a Immunology Division   (India)

^b NATIONAL JALMA INSTITUTE FOR LEPROSY AND OTHER MYCOBACTERIAL DISEASES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; CYTOKINE; DAPSONE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; LEPROMIN; LEPROSTATIC AGENT; MINOCYCLINE; MYCOBACTERIUM ANTIGEN; OFLOXACIN; PHENOLIC GLYCOLIPID I; RIFAMPICIN;

ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LEPROMATOUS LEPROSY; LEPROMIN TEST; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFORMATION TEST; MALE; MONONUCLEAR CELL; MYCOBACTERIUM LEPRAE; PROVOCATION TEST; TREATMENT OUTCOME;

ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOLIPIDS; HUMANS; HYPERSENSITIVITY, DELAYED; LEPROMIN; LEPROSY, LEPROMATOUS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MYCOBACTERIUM LEPRAE;

EID: 0035717730     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Antibodies to phenolic glycolipid I and to whole Mycobacterium leprae in leprosy patients; evolution during therapy
2. Localized lepromatous leprosy and its response to chemo-immunotherapy
3. The influence of antimycobacterial chemotherapy on delayed-type hypersensitivity
4. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression
5. Examination for Mycobacterium leprae
6. Induction of Th1 cytokine responses by mycobacterial antigens in leprosy
7. Effect of treatment on immune responsiveness in lepromatous leprosy patients
8. The immunology of leprosy
9. T cell conditioned media reverse T cell unresponsiveness in lepromatous leprosy
10. Functional heterogeneity among CD4+ T cell clones from blood and skin lesion of leprosy patients; identification of T cell clones distinct from Th0, Th1 and Th2
11. Demonstration of Mycobacterium leprae in tissues from bacteriologically negative treated lepromatous leprosy patients
12. Interferon-γ differentially regulates interleukin-12 and interleukin-10 production in leprosy
13. Cytokine profile of circulating T cells of leprosy patients reflects both indiscriminate and polarised T-helper subsets: T helper phenotype is stable and uninfluenced by regulated antigens of Mycobacterium leprae
14. Monocyte derived IL-10 and PGE2 are associated with the absence of Th1 cells and in vitro T cell suppression in lepromatous leprosy
15. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties
16. Cytokines in leprosy. II. Effect of treatment on serum cytokines in leprosy
17. T cell-derived IL-10 antagonizes macrophages function in mycobacterial infection
18. Analysis of cytokine production by mycobacterium-reactive T cells; failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients
19. Comparative evaluation of serological assays for lepromatous leprosy
20. Immune responsiveness to Mycobacterium leprae and mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy
21. Circulating T-cell numbers and their mitogenic potential in leprosy - Correlation with mycobacterial load
22. Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity
23. Defective gamma interferon production in leprosy; reversal with antigen and interleukin 2
24. A look at world leprosy
25. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy; the effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants
26. Bacterial indices
27. Classification of leprosy according to immunity; a five-group system
28. Serological monitoring of the response to chemotherapy in leprosy patients
29. Appraisal of two Mycobacterium leprae-specific serological assays for monitoring chemotherapy in lepromatous (LL/BL) leprosy patients
30. Changes in cellular response to mycobacterial antigens and cytokine production patterns in leprosy patients during multiple drug therapy
31. Type 1- and type 2-like lesional skin-derived Mycobacterium leprae-responsive T cell clones are characterized by coexpression of IFn-γ/TNF-α and IL-4/IL-5/IL-13, respectively
32. Tuberculoid relapse in lepromatous leprosy
33. Positive Mitsuda lepromin reactions in long-term-treated lepromatous leprosy
34. Defining protective responses to pathogens: Cytokine profiles in leprosy lesions